Patent · US Active

Compound for the treatment of enteroviruses

US8796273B2 · kind B2 · utility

1Cited by

0References

7Claims

0Family size

Assignee

BIOTA SCIENTIFIC MANAGEMENT PTY LTD · AU

Inventors

Johan Neyts · Namur, BE
Armando De Palma · Leuven, BE
Hendrik Jan Thibaut · Namur, BE
Pieter Leyssen · Leuven, BE
Simon Tucker · Black Rock, AU

Key dates

Filing date	Jun 24, 2011
Grant date	Aug 5, 2014
Priority date	—
Expiry date	Mar 16, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the treatment, alleviation, prevention or reduction in the incidence of symptoms, diseases or conditions resulting from or associated with enteroviruses, more particularly the enteroviral infections they cause.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.